• 
  Thomas F Baumert, Melanie Urbanek-Quaing, Markus Cornberg. Immunomodulation and entry inhibition: selgantolimod’s double punch against hepatitis B virus. Gut, 2024, 73 (12), pp.1925-1926. ⟨10.1136/gutjnl-2024-332679⟩. ⟨hal-04780717⟩
• 
  Valerio Taverniti, Laura Meiss-Heydmann, Cloe Gadenne, Hannah Vanrusselt, Dieudonné Buh Kum, et al.. CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1.. JHEP reports : innovation in hepatology, 2024, 6 (10), ⟨10.1016/j.jhepr.2024.101134⟩. ⟨hal-04757453⟩
• 
  Pierre Tonnerre, Thomas F. Baumert. Unraveling the liver antiviral immunity in functional cure of chronic hepatitis B using scRNAseq. Journal of Hepatology, 2024, 81 (1), pp.14-16. ⟨10.1016/j.jhep.2024.03.017⟩. ⟨hal-04700783⟩
• 
  Kristina Pravoverov, Iram Fatima, Susmita Barman, Frank Juehling, Mark Primeaux, et al.. IL-22 regulates MASTL expression in intestinal epithelial cells. American journal of physiology. Gastrointestinal and liver physiology, 2024, 327 (2), pp.G123-G139. ⟨10.1152/ajpgi.00260.2023⟩. ⟨hal-04709853⟩
• 
  Klas Hatje, Tony Kam-Thong, Nicolas Giroud, Antonio Saviano, Pauline Simo-Noumbissie, et al.. Single-cell RNA-sequencing of virus-specific cellular immune responses in chronic hepatitis B patients.. Scientific Data , 2024, 11 (1), pp.355. ⟨10.1038/s41597-024-03187-2⟩. ⟨hal-04700769⟩
• 
  Atish Mukherji, Frank Juehling, Yogy Simanjuntak, Emilie Crouchet, Fabio del Zompo, et al.. An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection.. Nature Communications, 2024, 15 (1), pp.7486. ⟨10.1038/s41467-024-51698-8⟩. ⟨hal-04699545⟩
• 
  Antonio Saviano, Thomas Baumert. Mortality from liver cirrhosis and HCC in the DAA era: success in viral control is darkened by raise of metabolic disease. Hepatobiliary Surgery and Nutrition, 2019, 8 (3), pp.307-310. ⟨10.21037/hbsn.2019.01.21⟩. ⟨hal-02440070⟩
• 
  Nicolaas van Renne, Armando Andres Roca Suarez, Francois Duong, Claire Gondeau, Diego Calabrese, et al.. miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis. Gut, 2018, 67 (5), pp.953 - 962. ⟨10.1136/gutjnl-2016-312270⟩. ⟨hal-01837106⟩
• 
  Emilie Crouchet, Florian Wrensch, Catherine Schuster, Mirjam Zeisel, Thomas F. Baumert. Host-targeting therapies for hepatitis C virus infection: current developments and future applications. Therapeutic Advances in Gastroenterology, 2018, 11, pp.1756284818759483. ⟨10.1177/1756284818759483⟩. ⟨hal-02460232⟩
• 
  Natascha Roehlen, Armando Andres Roca Suarez, Houssein El Saghire, Antonio Saviano, Catherine Schuster, et al.. Tight Junction Proteins and the Biology of Hepatobiliary Disease.. International Journal of Molecular Sciences, 2020, 21 (3), pp.825. ⟨10.3390/ijms21030825⟩. ⟨hal-02917277⟩

166

131